GoodRx Holdings, Inc. operates a digital healthcare platform focused on prescription and medication savings in the United States. Company news commonly covers prescription transaction revenue, retail pharmacy trends, negotiated discount pricing, PBM relationships, and the expansion of Pharma Direct manufacturer programs that connect branded drug discounts to consumers at the pharmacy counter.
GoodRx updates also include self-pay pricing arrangements for GLP-1 and other branded medications, subscription health services such as condition-specific programs, earnings releases, business outlook commentary, and partnerships with pharmaceutical manufacturers, pharmacies, payers, and healthcare professionals.
GoodRx (GDRX) has expanded benefits for its subscription service, GoodRx Gold, offering members exclusive discounts on online doctor visits and free mail delivery. Members can now access affordable healthcare from home, with telehealth visits starting at $10. The service includes mail delivery for over 1,000 medications, with many under $10. After a 30-day free trial, the subscription costs $5.99 monthly for individuals and $9.99 for families. The average member saves over $2,875 annually. GoodRx aims to enhance access to healthcare as telehealth interest rises post-COVID-19 pandemic.
GoodRx Holdings Inc. (Nasdaq: GDRX) announced its third quarter 2020 financial results, highlighting its ongoing mission to make healthcare affordable. With over $25 billion saved by Americans since 2011, GoodRx remains a leading resource for healthcare savings, providing affordable prescriptions and telehealth services. Investors can access the Q3 results and shareholder letter on the investor relations website. A conference call is scheduled for today to discuss these results and the company’s outlook.
GoodRx Holdings Inc. (Nasdaq: GDRX) announced participation in several upcoming virtual investor conferences. Key events include the RBC Capital Markets Conference on November 18 at 7:15am PT, the Credit Suisse Technology Conference on December 3 at 9:50am PT, the UBS Global TMT Conference on December 8 at 11:50am PT, and the Barclays Global Conference on December 10 at 10:00am PT. Live webcasts and archived recordings will be available on the Company’s Investor Relations website post-conference.
GoodRx has saved Americans over $20 billion since 2011.
GoodRx Holdings Inc. (Nasdaq: GDRX) announced the release of its third quarter 2020 financial results on November 12, 2020, before the U.S. market opens. A conference call will follow at 5:30 a.m. PT to discuss the results and future outlook. The company has aided Americans in saving over $20 billion since 2011. GoodRx is recognized as the #1 most downloaded medical app over the past three years, reflecting its strong market presence in consumer-focused digital healthcare.
GoodRx Holdings, Inc. (Nasdaq: GDRX) has renewed its partnership with Kroger Health for three years, enhancing access to the Kroger Rx Savings Club. This initiative aims to help customers save on prescription medications, offering discounts of up to 85% on various generic drugs. Since their collaboration began in 2018, GoodRx has enabled significant savings for over 18 million Americans, totaling $20 billion. The Kroger Rx Savings Club provides multiple tiers of low-cost medications, which are especially beneficial for uninsured individuals or those facing high copays.